3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Prostatic Neoplasms
2
Lymphoma
2
Sleep Initiation and Maintenance Disorders
1
Sedentary Behavior
1
Oligodendroglioma
1
Meningioma
1
Leukemia, Myeloid, Acute
1
Glioma
1
Glioblastoma
1
Fatigue
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
29
Bevacizumab
12
Radiotherapy
10
Irinotecan
7
Carboplatin
7
Carmustine
5
Magnetic Resonance Spectroscopy
4
Filgrastim
4
Cyclophosphamide
4
Cisplatin
4
Vincristine
3
Thiotepa
3
Surgical Procedures, Operative
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
talampanel
2
sargramostim
2
antineoplaston AS 2-1
2
antineoplaston A10
2
abemaciclib
2
Topotecan
2
Thalidomide
2
Tamoxifen
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Procarbazine
2
Immunoglobulin G
2
Everolimus
2
Drug Therapy
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Oligodendroglioma
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled